top of page

C3 Team Members

Dr. Rebecca Auer

Dr. Rebecca Auer

C3 Hope Lead

Lead for the overall C3 Program and oversees the Research Navigator and C3-HOPE

Dr. Carmen Loiselle

Dr. Carmen Loiselle

C3 HOPE Study

​

Dr. Samar Attieh

Dr. Samar Attieh

C3 HOPE Study

​

Dr. John Bell

Dr. John Bell

C3 STAR-C
C3 IMPACT

C3 Team Mentor and Scientific Advisor

Dr. Sandy Pelletier

Dr. Sandy Pelletier

C3 STAR-C Cell Manufacturing (Montreal)

Montreal Cell Manufacturing of TIL products Lead

Dr. Trevor Pugh

Dr. Trevor Pugh

C3 IMPACT-WGTS

Oversight on whole genome and transcriptome sequencing (WGTS), and tumour-specific and neoAG prediction

Dr. Scott Brown

Dr. Scott Brown

C3 IMPACT

C3 IMPACT-MB

Dr. Simon Turcotte

Dr. Simon Turcotte

C3 STAR-C Lead

Lead for STAR-C Clinical Trial

Dr. Rachel Goodwin

Dr. Rachel Goodwin

C3 HOPE-Rounds

​

Christine Lafontaine

Christine Lafontaine

C3 HOPE Research Navigator

​

Dr. Rachel Goodwin

Dr. Rachel Goodwin

C3 HOPE

Co-Chair for Multidisciplinary Cholangiocarcinoma Rounds

Dr. Mathieu Crupi

Dr. Mathieu Crupi

C3 STAR-C Cell Manufacturing (Ottawa)

C3 Cell Manufacturing Team (Ottawa)

Dr. Brad Nelson

Dr. Brad Nelson

C3 IMPACT-PRO

Immunoprofiling samples by multi-colour immunofluorescence (mcIF) techniques

Dr. Zaid Taha

Dr. Zaid Taha

C3 IMPACT

C3 IMPACT-OV

Dr. Carolina Ilkow

Dr. Carolina Ilkow

C3 IMPACT and C3 IMPACT-OV Lead

Lead for C3 IMPACT

Dr. Leonard Angka

Dr. Leonard Angka

C3 Program Manager

Managing the milestones and deliverables of the C3 program initiatives

Melinda Bachini

Melinda Bachini

C3 HOPE - Patient Advocate

​

Dr. Jennifer Quizi

Dr. Jennifer Quizi

C3 STAR-C

Ottawa Cell Manufacturing of TIL products Lead

Dr. Laszlo Radvanyi

Dr. Laszlo Radvanyi

C3 IMPACT-TA

Researching the link between extracellular vesicles (EVs) and cholangiocarcinoma to find neo-tumour antigens

Dr. Rob Holt

Dr. Rob Holt

C3 IMPACT-MB

Profiling the tumour microbiome of cholangiocarcinoma/normal tissue samples

  • Facebook
  • Instagram
  • LinkedIn
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page